Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 9661 | Ordered by Date (descending)
1 2 3 ... 95 96 97  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Actelion–Enamine: chemical compound library, 201701– collab expansion supply of screening compound library to Actelion 2017-01-23
Merck (DE)–Domain Therapeutics: cancer drugs, 201701– collab developm + ww license to adenosine receptor antagonists 2017-01-23
Affimed–SEVERAL: investment, 201701 public offering $18m+$2.7m w 10m+1.5m common shares at $1.8/share 2017-01-19
Asahi Kasei–Evotec: drug discovery, 201701– supply service €na expansion into integrated drug discovery collab for inhibitors of ion channel targets 2017-01-19
Fibrocor Therapeutics–Evotec: drug discovery services, 201701– collab developm fibrosis drugs w all drug discovery activities done by Evotec 2017-01-17
Fibrocor Therapeutics–Evotec: investment, 201701 Evotec to receive equity stake in Fibrocor as part of collaboration 2017-01-17
Fibrocor Therapeutics–SEVERAL: investment, 201701 seed financing C$2.8m ($2.1m) incl cash from co-founder MaRS Innovation 2017-01-17
Luxendo–Huntsworth: public relations, 201701 service existent by Citigate Dewe Rogerson 2017-01-12
Luxendo–SEVERAL: investment, 201701 financing round Series A extension €2m bringing total to €8m co-led by LSP + EMBL Ventuers + EMBLEM 2017-01-12
MorphoSys–JPMorgan Chase: investor conference, 201701 supply service MorphoSys presents at JP Morgan Healthcare Conference 2017 2017-01-12
Tecan–JPMorgan Chase: investor conference, 201701 supply service Tecan Group presents at JP Morgan Healthcare Conference 2017 2017-01-11
Crescendo Biologics–Genedata: bioinformatics, 201701– license to Genedata Biologics as workflow platform for internal + partnered Humabody programs 2017-01-10
CureVac–JPMorgan Chase: investor conference, 201701 supply service CureVac presents at JP Morgan Healthcare Conference 2017 2017-01-09
Epidarex Capital–Lilly: investment, 201701 existent one of several investors in Epidarex is Eli Lilly 2017-01-09
Eternygen–Berlin (govt): investment, 201701 financing round Series A totalling €8m incl co-investor VC Fonds Technologie managed by IBB 2017-01-09
Eternygen–Epidarex Capital: investment, 201701 financing round Series A totalling €8m incl lead investor Epidarex Capital 2017-01-09
Eternygen–Evotec: investment, 201701 financing round Series A totalling €8m incl co-investor Evotec AG 2017-01-09
Eternygen–MC Services: public relations, 201701 service existent by MC Services AG 2017-01-09
Eternygen–SEVERAL: investment, 201701 financing round Series A €8m led by Epidarex Capital plus Evotec + VC Fonds Technologie + 2 family offices et al 2017-01-09
Merck (DE)–Univ Texas: oncology, 201701–201912 strategic collab using MD Anderson’s APOLLO platform for cancer drug development 2017-01-09
OmicSoft–Qiagen: investment, 201701 acquisition €na of OmicSoft by Qiagen 2017-01-09
Anokion–Celgene: investment, 201701 acquisition of equity interest by Celgene as part of research collab research plus excl option to acquire Anokion 2017-01-08
Celgene–Anokion: immune tolerance inducing drugs, 201701– collab research $45m upfront + $10m milestones + equity share + right to acquire Anokion 2017-01-08
HepaRegenix–Boehringer: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–Germany (govt): investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–High-Tech Gründerfonds: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–MC Services: public relations, 201701 service existent by MC Services AG 2017-01-05
HepaRegenix–Novo Group: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–SEVERAL: investment, 201701 financing round Series A €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
Merck (US)–Valneva: cell line, 201701– research license €na for development of new vaccines using EB66 technology to MSD Animal Health 2017-01-05
Servier–Pieris: cancer immunotherapy, 201701– collab €30m upfront + milestones to develop bi-specific ABs using Anticalin technology incl PRS-322 2017-01-05
Xigen–Instinctif Partners: public relations, 201701 service existent by Instinctif Partners 2017-01-05
Affimed–Univ Texas: cancer immunotherapy, 201701– collab clinical + commerc to evalaute TandAbs with natural killer cell product of MD Anderson 2017-01-04
AiCuris–MC Services: public relations, 201701 service existent by MC Services AG Düsseldorf 2017-01-04
Aptarion Biotech–Noxxon: investment, 201701 Noxxon receives Aptarion shares as part of transfer of preclinical assets to Aptarion 2017-01-04
Aptarion Biotech–Noxxon: Spiegelmer technology, 201701 acquisition techn + preclinical assets + lab assets from Noxxon for cash + royalties + shares 2017-01-04
BioControl Systems–Merck (DE): investment, 201701 acquisition €na of BioControl Systems Inc by Merck KGaA 2017-01-04
InVivo Biotech Services–Bruker Corp: investment, 201701 acquisition €na of InVivo Biotech Services GmbH by Bruker 2017-01-04
SCiLS GmbH–Bruker Corp: investment, 201701 acquisition €na of SCiLS GmbH by Bruker 2017-01-04
Laboratoire LCA (MA)–SGS: investment, 201701 acqisition by SGS 2017-01-03
Ridgeway Biologicals–Klocke: investment, 201701 acquisition of Ridgeway Biologicals by IDT Biologika 2017-01-01
Genkyotex–Genticel: investment, 201612– reverse merger with Genkyotex’ owners holding 80% of merged entity 2016-12-22
Laagrima (MA)–SGS: investment, 201612 acquisition by SGS 2016-12-21
C-Labs (CH)–SGS: investment, 201612 acquisition of controlling stake by SGS 2016-12-19
Active Spectrum–Bruker Corp: investment, 201612 acquisition €na of Active Spectrum by Bruker 2016-12-16
Ziarco–Novartis: investment, 201612 acquisition €na by Novartis ANNOUNCED 2016-12-16
Bluebird Bio–Apceth: contract manufacturing, 201612– collab strategic European manufacturing of Lenti-D + LentiGlobin by Apceth Biopharma GmbH 2016-12-15
Kohlberg Kravis Roberts–Lonza: investment, 201612– acquisition of Capsugel for $5.5b in cash from KKR by Lonza 2016-12-15
Noxxon–Merck (US): cancer immunotherapy, 201612– collab clinical research combi of Keytruda + NOX-A12 in metastatic colorectal + pancreatic cancer 2016-12-15
Acousia Therapeutics–SEVERAL: investment, 201612 financing round €2.5m led by BIVF + incl KfW + Axxam 2016-12-14
Amcure–SEVERAL: investment, 201612 financing round Series B €6m led by LBBW Venture Capital GmbH 2016-12-14
Gilupi–Viroad: investment, 201612 acquisition of remaining shares in Gilupi by Viroad after becoming largest shareholder in 2012 2016-12-14
Carpegen–Systec Elektronik: real-time PCR technology, 201612 collab existent development of Gyronimo platform co-owned by Carpegen + Systec 2016-12-13
Curetis–Carpegen: real-time PCR technology, 201612 acquisition €5m cash + €2.5m+€9m milestones of Gyronimo platform from Carpegen + Systec 2016-12-13
Genome Diagnostics–Illumina: DNA sequencing, 201612– collab GenDx non-excl reseller of Illumina porudcts for HLA sequencing in several countries 2016-12-13
BlueRock Therapeutics–Bayer: investment, 201612– financing round Series A totalling of $225m committed by Bayer + Versant Ventures 2016-12-12
BlueRock Therapeutics–SEVERAL: investment, 201612– launches with financing round Series A $225m committed by Bayer + Versant Ventures 2016-12-12
BlueRock Therapeutics–Versant Ventures: investment, 201612– financing round Series A totalling of $225m committed by Bayer + Versant Ventures 2016-12-12
Curetis–EU (govt): credit, 201612– up to €25m (incl €10m immediately) growth capital loan from EBI to advance Unyvery platform 2016-12-12
EURE-CART project–EU (govt): grant, 201612c– Horizon 2020 grant €5.9m 4y for clinical research on CART T-cell immunotherapy 2016-12-12
MolMed–EU (govt): grant, 201612c– Horizon 2020 grant €2m for MolMed for 4y as coordinator of EURE-CART project 2016-12-12
Biopremier (PT)–SGS: investment, 201612 acquisition of 70% stake by SGS 2016-12-09
Forge Therapeutics–Evotec: drug discovery services, 201612– collab strategic alliance lead optimisation of LpxC inhibitors by Evotec 2016-12-09
TCR2 Therapeutics–F2 Ventures: investment, 201612 financing round Series A totalling $44.5m led by MPM Capital + F2 Ventures 2016-12-07
TCR2 Therapeutics–MPM Capital: investment, 201612 financing round Series A totalling $44.5m led by MPM Capital + F2 Ventures 2016-12-07
TCR2 Therapeutics–SEVERAL: investment, 201612 financing round Series A $44.5m led by MPM Capital + F2 Ventures 2016-12-07
Roche–Novimmune: therapeutic antibody, 201612– excl license option €na for all rights to NI-0101 for autoimmune diseases to Genentech 2016-12-06
Acticor Biotech–Merck (DE): rec protein production, 201612– supply Provantage End-to-End Services for developm + manufacturing of Fab 2016-12-05
Bayer–FaunaPhotonics: digital farming technology, 201612– collab developm sensor technology for insect pest monitoring w Bayer CropScience 2016-12-05
JnJ–AstraZeneca: budenoside, 201612 acquisition $330m of ww rights excl US to Rhinocort Aqua by Cilag GmbH International 2016-12-05
International Phenome Centre Network–Bruker Corp: NMR technology, 201611– collab Bruker is key partner for NMR technologies + methods + SOPs 2016-12-02
International Phenome Centre Network–Imperial College London: phenomics, 201611– collab MRC-NIHR UK Phenome Centre is founding partner of IPCN 2016-12-02
International Phenome Centre Network–Murdoch Univ: phenomics, 201611– collab Separation Science + Metabolomics Lab is founding partner of IPCN 2016-12-02
Celgene–Evotec: drug discovery services, 201612–202111 strategic RnD collab $45m upfront using iPSC platform for drugs neurodegenerative diseases 2016-12-01
Valneva–France (govt): investment, 201612 existent Bpifrance is 2nd largest shareholder owning 9.6% 2016-12-01
Valneva–Grimaud: investment, 201612 existent Groupe Grimaud is largest shareholder owning 15.6% 2016-12-01
Valneva–MVM: investment, 201612 private placement €7.5m w 2.9m new shares at €2.6 to MVM plus acqu existing shares results in 7.5% MVM share 2016-12-01
Boehringer–ACD/Labs: cheminformatics, 201611– supply deployment of ACD/Spectrus platform by Boehringer in Europe + North America 2016-11-30
Evotec–Merck (DE): target discovery technology, 201611– collab agreements to combine Merck genome editing technologies w Evotec screening (LT) 2016-11-30
G7 Therapeutics–Sosei: investment, 201611– acquisition 100% for CHF12m in cash of G7 Therapeutics by Heptares 2016-11-30
Zedira–Germany (govt): grant, 201611– BMBF KMU-Innovativ funding €1.5m for 3y to support developm of ZED1227 in diabetic nephropathy 2016-11-30
AudioCure Pharma–High-Tech Gründerfonds: investment, 201611 financing round totalling €9m from new investor MED-EL + HTGF + private investors 2016-11-29
AudioCure Pharma–MED-EL: investment, 201611 financing round totalling €9m from new investor MED-EL + HTGF + private investors 2016-11-29
AudioCure Pharma–SEVERAL: investment, 201611 financing round €9m from new investor MED-EL + existing investor HTGF + private investors 2016-11-29
Jackson Laboratory–Agilent: grant, 201611– Thought Leader Award to Peter Robinson at Jackons Lab for Genomic Medicine for clinical genomics research 2016-11-28
Menarini–Chugai: cancer drug, 201611– license ww excl for class I PI3K inhibitor PA799 to Berlin-Chemie Menarini 2016-11-28
Themis Bioscience–SEVERAL: investment, 201611 financing round Series B €10m 2nd + final closing with additional €3m 2016-11-28
Actelion–JnJ: investment, 201611– confirmed discussion about a possible acquisition of Actelion by JnJ 2016-11-25
Abivax–Deutsche Börse: investor conference, 201611 supply service Abivax presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Biofrontera–Deutsche Börse: investor conference, 201611 supply service Biofrontera presents at Deutsches Eigenkapitalforum 2016 2016-11-22
BRAIN–Deutsche Börse: investor conference, 201611 supply service BRAIN AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Epigenomics–Deutsche Börse: investor conference, 201611 supply service Epigenomics AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Evotec–Deutsche Börse: investor conference, 201611 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Formycon–Deutsche Börse: investor conference, 201611 supply service Formycon AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Kiadis–Deutsche Börse: investor conference, 201611 supply service Kiadis Pharma NV presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Merck (US)–Proteros: drug discovery services, 201611– collab €na upfront + research funding + $167m milestones + royalties r+d small mol cancer drug 2016-11-22
Mologen–Deutsche Börse: investor conference, 201611 supply service Mologen AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Newron–Deutsche Börse: investor conference, 201611 supply service Newron Pharmaceuticals presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Nicox–Deutsche Börse: investor conference, 201611 supply service Nicox SA presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Paion–Deutsche Börse: investor conference, 201611 supply service Paion AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
1 2 3 ... 95 96 97  next pagenext page



Advertisement

Picture VIB Conferences Revolutionizing Next Gen Sequencing 2017 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Sacura e.tract software 2017 600x60px wpctoc

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture VIB Conferences Revolutionizing Next Gen Sequencing 2017 120x180px Picture BIO Deutschland Dt Biotechnologietage DBT 2017 Hannover April 120x240px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture Sacura e.tract software 2017 120x240px wpctoc Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px